...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> Ganymed’s IMAB362 Shows Strong Evidence of Single-Agent Activity in Phase IIa Trial in Gastroesophageal Cancer
05/27/14
> Appointment of Jens Klein as Managing Director of AMSilk GmbH
05/23/14
> H3 Biomedicine and Selvita Reach First Research Milestone in Precision Cancer Medicines Collaboration
05/22/14
> Mucosis Receives Financial Support from the Dutch Government for its SynGEM® Program
05/22/14
> Dr. Brian Zambrowicz, Ph.D Has Joined Nuevolution as Director and Senior Scientific Advisor to the Board of Directors
05/21/14
> KBI Biopharma Acquires Biologics Operations in Colorado
05/13/14
> Lophius Biosciences Secures EUR 2,0 Million Financing and Announces Leadership Changes
05/08/14
> Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG
05/05/14
> Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining as CFO/CBO to Lead U.S. Site
04/24/14
> ZZ Biotech Announces Phase 2 Trial with 3K3A-APC in Stroke; Funds Will Be Provided by NIH and Broadview Ventures
04/22/14
> Aspireo Reports Data in Further Phase Ib Study
04/22/14
> Critical Pharmaceuticals, The University of Nottingham and Nottingham University Hospitals NHS Trust Starts First Phase I Clinical Trial on a Nano-Enabled Intranasal Teriparatide for the Treatment of Osteoporosis
04/15/14
> Mucosis Announces a Strategic Partnership with Changchun Bcht Biotechnology of China and Raises Additional Capital
04/15/14
> Albireo’s Lead Compound in Cholestatic Liver Diseases, A4250, Protects Against Bile Acid-Mediated Cholestatic Liver Injury in Mice
04/11/14
> Vetter Launches New Clinical Syringe Packages
04/09/14
> Critical Pharmaceuticals Receives Notice of Allowance from US Patent and Trademark Office for Intranasal Growth Hormone and Parathyroid Hormone Products
04/08/14
> Domainex Programme Shows Great Promise for the Treatment of Inflammatory Diseases, Such as Chronic Obstructive Pulmonary Disease (COPD)
04/07/14
> Grace Launches ProVance Disposable Protein A Chromatography Columns to Help Reduce Costs and Time to Market for Biologics
04/07/14
> Haselmeier Announces the Market Launch of JuniorSTAR® by Sanofi
04/03/14
> Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells
04/03/14
> Biametrics Successfully Finalizes Feasibility Study with MorphoSys in the Area of High-Throughput Antibody Screening
04/01/14
> Vetter to Implement Serialization to Support Track-And-Trace Efforts
03/27/14
> CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO
03/24/14
> BioOutsource Launches Flagship Reverse Signaling Apoptosis Bioassay
03/24/14
> Biametrics Launches b-screen® Microarray Screening Device
03/18/14
> Rentschler Announces 3rd INDUSTRIAL CELL CULTURE TECHNOLOGY CONFERENCE on Processes for Virus-based Biologics
03/14/14
> Formycon AG Appoints Top US Pharmaceuticals Manager Bernhard Hampl to the Advisory Board
03/13/14
> Formycon AG: Licensing Out of the First Biosimilar Development Project Already Enables Extension of the Product Pipeline as of 2014
03/12/14
> Selvita Will Present New Data from Its PIM/FLT3 and MNK1/2 Oncology Programs during AACR Annual Meeting 2014
03/11/14
> Cevec Announces that CAP Cells Produce High Titers of RSV Vaccine
03/10/14
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 2 of 32